Evidence map›Paper›PMID 28893781›Full record

ArticleAntimicrobial agents and chemotherapy2017

Identification of Heparin Modifications and Polysaccharide Inhibitors of Plasmodium falciparum Merozoite Invasion That Have Potential for Novel Drug Development.

Michelle J Boyle, Mark Skidmore, Benjamin Dickerman, Lynsay Cooper, Anthony Devlin, Edwin Yates, Paul Horrocks, Craig Freeman, Wengang Chai, James G Beeson

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Unveiling the Sugary Secrets ofFrontiers in microbiology · 2021
    Review
  10. Article
  11. Heparin Administered toBiomolecules · 2020
    Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Michelle J BoyleThe Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia michelle.boyle@burnet.edu.au james.beeson@burnet.edu.au.ORCID 0000-0002-0268-232X
Mark SkidmoreSchool of Life Sciences, Keele University, Staffordshire, United Kingdom.
Benjamin DickermanThe Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia.
Lynsay CooperSchool of Life Sciences, Keele University, Staffordshire, United Kingdom.
Anthony DevlinSchool of Life Sciences, Keele University, Staffordshire, United Kingdom.
Edwin YatesSchool of Life Sciences, Keele University, Staffordshire, United Kingdom.
Paul HorrocksSchool of Life Sciences, Keele University, Staffordshire, United Kingdom.
Craig FreemanCancer and Vascular Biology Group, Department of Immunology, The John Curtin School of Medical Research, The Australian National University, Canberra, Australia.
Wengang ChaiGlycosciences Laboratory, Imperial College London, Hammersmith Campus, London, United Kingdom.
James G BeesonThe Burnet Institute for Medical Research and Public Health, Melbourne, Victoria, Australia michelle.boyle@burnet.edu.au james.beeson@burnet.edu.au.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Despite recent successful control efforts, malaria remains a leading global health burden. Alarmingly, resistance to current antimalarials is increasing and the development of new drug families is needed to maintain malaria control. Current antimalarials target the intraerythrocytic developmental stage of the

Indexed as

AntimalarialsDrug DiscoveryDrug ResistanceHeparinMalaria, FalciparumMerozoitesPlasmodium falciparumPolysaccharidesAntimalarialsHeparinPolysaccharidesheparininvasionmerozoitePlasmodium falciparumpolysaccharide

Identifiers

PMID28893781
PMCPMC5655105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.